Johnson & Johnson - Strategy, SWOT and Corporate Finance Report

Johnson & Johnson - Strategy, SWOT and Corporate Finance Report

Summary

Johnson & Johnson - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the companys structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360 degree view of the company.

Key Highlights

Johnson & Johnson (J&J or the company) is a health care company that develops, manufactures and markets consumer health care products, pharmaceuticals and medical devices. It offers pharmaceuticals in the therapeutic areas of immunology, oncology, neuroscience, infectious diseases and vaccines, pulmonary hypertension, cardiovascular and metabolism. The company markets its products under Simponi, Remicade, Stelara, Aveeno, Clean & Clear, Dabao, Johnsons Adult, Le Petite Marseillais, Neutrogena and Ogx brand names. Its medical devices include general surgery, biosurgical, endomechanical and energy products; electrophysiology products, vision products and phthalmic products. The company buy raw material from multiple sources. J&J distributes its pharmaceutical products, medical devices and consumer products to retailers, wholesalers, health care professionals and hospitals and through a network of retail outlets and distributors. It has business presence across the Americas, Europe, Asia-Pacific and Africa. The company is headquartered in New Brunswick, New Jersey, the US.

Scope

- Detailed information on Johnson & Johnson required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Johnson & Johnson in the form of a SWOT analysis
- An in-depth view of the business model of Johnson & Johnson including a breakdown and examination of key business segments
- Intelligence on Johnson & Johnsons mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Johnson & Johnson, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to Buy

- Gain understanding of Johnson & Johnson and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Johnson & Johnson as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers businesses better.
- Stay up to date on Johnson & Johnsons business structure, strategy and prospects.

Company Snapshot
Johnson & Johnson: Company Overview
Johnson & Johnson: Overview and Key Facts
Johnson & Johnson: Overview
Johnson & Johnson: Key Facts
Johnson & Johnson: Key Employees
Johnson & Johnson: Key Employee Biographies
Johnson & Johnson: Major Products and Services
Johnson & Johnson: Company History
Johnson & Johnson: Management Statement
Johnson & Johnson: Locations and Subsidiaries
Johnson & Johnson: Key Competitors
Johnson & Johnson: Company Analysis
Johnson & Johnson: Business Description
Johnson & Johnson: SWOT Analysis
Johnson & Johnson: SWOT Overview
Johnson & Johnson: Strengths
Johnson & Johnson: Weaknesses
Johnson & Johnson: Opportunities
Johnson & Johnson: Threats
Johnson & Johnson: Corporate Financial Deals Activity
Johnson & Johnson: Financial Deals Overview
Johnson & Johnson: Targets and Partners
Johnson & Johnson: Top Deals 2016 - 2020YTD*
Johnson & Johnson: Advisors
Johnson & Johnson: Top Legal Advisors
Johnson & Johnson: Top Financial Advisors
Johnson & Johnson: Mergers and Acquisitions
Johnson & Johnson: Corporate Venturing
Johnson & Johnson: Capital Raising
Johnson & Johnson: Partnership
Johnson & Johnson: Divestments
Johnson & Johnson: Recent Developments
Johnson & Johnson: News and Events Summary
Johnson & Johnson: Business Expansion
Johnson & Johnson: Contracts
Johnson & Johnson: Financial Deals
Johnson & Johnson: Regulatory and Legal Events
Johnson & Johnson: Research & Development
Johnson & Johnson: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List Of Tables

List of Tables
Table 1: Johnson & Johnson: Key Facts
Table 2: Johnson & Johnson: Key Employees
Table 3: Johnson & Johnson: Company History
Table 4: Johnson & Johnson: Locations and Subsidiaries
Table 5: Johnson & Johnson: Key Competitors
Table 6: Johnson & Johnson: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Johnson & Johnson: M&A Activity by Geography (TTM*)
Table 8: Johnson & Johnson: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 9: Johnson & Johnson: M&A Average Deal Size - Value (US$m)
Table 10: Johnson & Johnson: Targets and Partners
Table 11: Johnson & Johnson: Top Deals 2016 - 2020YTD*
Table 12: Johnson & Johnson: Legal Advisor Ranking by Value (US$m)
Table 13: Johnson & Johnson: Financial Advisor Ranking by Value (US$m)
Table 14: Johnson & Johnson: M&A Volume and Value Trend (2016 - YTD*2020)
Table 15: Johnson & Johnson: M&A Activity by Geography (2016 - YTD*2020)
Table 16: Johnson & Johnson: Corporate Venturing Volume and Value Trend (2016 - YTD*2020)
Table 17: Johnson & Johnson: Corporate Venturing by Geography (2016 - YTD*2020)
Table 18: Johnson & Johnson: Capital Raising Volume and Value Trend (2016 - YTD*2020)
Table 19: Johnson & Johnson: Capital Raising by Deal Type (2016 - YTD*2020)
Table 20: Johnson & Johnson: Partnership Volume and Value Trend (2016 - YTD*2020)
Table 21: Johnson & Johnson: Partnership Trend by Deal Type (2016 - YTD*2020)
Table 22: Johnson & Johnson: Divestments Volume and Value Trend (2016 - YTD*2020)
Table 23: Johnson & Johnson: Divestments by Geography (2016 - YTD*2020)
Table 24: Johnson & Johnson: News and Events Summary
Table 25: Johnson & Johnson: Business Expansion
Table 26: Johnson & Johnson: Contracts
Table 27: Johnson & Johnson: Financial Deals
Table 28: Johnson & Johnson: Regulatory and Legal Events
Table 29: Johnson & Johnson: Research & Development
Table 30: Johnson & Johnson: Strategy and Operations

List Of Figures

List of Figures
Figure 1: Johnson & Johnson: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Johnson & Johnson: M&A Activity by Geography (TTM*)
Figure 3: Johnson & Johnson: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Figure 4: Johnson & Johnson: M&A Average Deal Size - Value (US$m)
Figure 5: Johnson & Johnson: M&A Volume and Value Trend (2016 - YTD*2020)
Figure 6: Johnson & Johnson: M&A Activity by Geography (2016 - YTD*2020)
Figure 7: Johnson & Johnson: Corporate Venturing Volume and Value Trend (2016 - YTD*2020)
Figure 8: Johnson & Johnson: Corporate Venturing by Geography (2016 - YTD*2020)
Figure 9: Johnson & Johnson: Capital Raising Volume and Value Trend (2016 - YTD*2020)
Figure 10: Johnson & Johnson: Capital Raising by Deal Type (2016 - YTD*2020)
Figure 11: Johnson & Johnson: Partnership Volume and Value Trend (2016 - YTD*2020)
Figure 12: Johnson & Johnson: Partnership Trend by Deal Type (2016 - YTD*2020)
Figure 13: Johnson & Johnson: Divestments Volume and Value Trend (2016 - YTD*2020)
Figure 14: Johnson & Johnson: Divestments by Geography (2016 - YTD*2020)

Johnson Johnson Full Year Operating Financial

Johnson & Johnson 2023 Full Year Operating and Financial Review--SWOT Analysis, Technological Know-How, M&A, Senior Management, Goals and Strategies in the Global Pharmaceutical Industry This report is part of the

USD 750 View Report

Johnson & Johnson 2023 Third Quarter Operating and Financial Review

Johnson & Johnson 2023 Third Quarter Operating and Financial Review--SWOT Analysis, Technological Know-How, M&A, Senior Management, Goals and Strategies in the Global Pharmaceutical Industry This report is part of the

USD 750 View Report

Johnson & Johnson 2023 Third Quarter Operating and Financial Review

Johnson & Johnson 2023 Third Quarter Operating and Financial Review--SWOT Analysis, Technological Know-How, M&A, Senior Management, Goals and Strategies in the Global Pharmaceutical Industry This report is part of the

USD 750 View Report

Johnson & Johnson 2023 First Half Operating and Financial Review

Johnson & Johnson 2023 First Half Operating and Financial Review--SWOT Analysis, Technological Know-How, M&A, Senior Management, Goals and Strategies in the Global Pharmaceutical Industry This report is part of the

USD 750 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available